<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Indian J Nucl Med</journal-id><journal-id journal-id-type="iso-abbrev">Indian J Nucl Med</journal-id><journal-id journal-id-type="publisher-id">IJNM</journal-id><journal-title-group><journal-title>Indian Journal of Nuclear Medicine : IJNM : The Official Journal of the Society of Nuclear Medicine, India</journal-title></journal-title-group><issn pub-type="ppub">0972-3919</issn><issn pub-type="epub">0974-0244</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24591791</article-id><article-id pub-id-type="pmc">3928759</article-id><article-id pub-id-type="publisher-id">IJNM-29-60</article-id><article-id pub-id-type="doi">10.4103/0972-3919.125784</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letters to Editor</subject></subj-group></article-categories><title-group><article-title>Rare splenic metastasis of renal cell carcinoma detected on <sup>99m</sup>Tc-MDP bone scan</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Agrawal</surname><given-names>Archi</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Jatale</surname><given-names>Prafulla</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Purandare</surname><given-names>Nilendu</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Shah</surname><given-names>Sneha</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Rangarajan</surname><given-names>Venkatesh</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib></contrib-group><aff id="aff1">Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Mumbai, Maharashtra, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Venkatesh Rangarajan, Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, E Borges Road, Parel, Mumbai - 400 012, Maharashtra, India. E-mail: <email xlink:href="drvrangarajan@gmail.com">drvrangarajan@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jan-Mar</season><year>2014</year></pub-date><volume>29</volume><issue>1</issue><fpage>60</fpage><lpage>61</lpage><permissions><copyright-statement>Copyright: &#x000a9; Indian Journal of Nuclear Medicine</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions></article-meta></front><body><p>Sir,</p><p><sup>99m</sup>Tc-methylene diphosphonate (MDP) uptake in soft tissues like primary breast mass, liver metastases, ascites, and pleural effusion are well-known entities. We here in report a rare case of splenic metastasis from renal cell carcinoma (RCC) which was detected on <sup>99m</sup>Tc-MDP bone scan. A 52-year-old male was a diagnosed case of clear cell carcinoma of the left kidney and had undergone nephrectomy 3 years ago. The patient was on regular follow-up and was disease free. However, a few months back he complained of severe backache. A bone scan done was done for evaluation of the bone pain. The <sup>99m</sup>Tc-MDP scan did not reveal any abnormally increased activity in the axial and appendicular skeleton. The left kidney was not visualized; post nephrectomy status. But, an area of soft tissue uptake of tracer was seen in the left hypochondrium [<xref ref-type="fig" rid="F1">Figure 1</xref>]. A contrast-enhanced computed tomography (CECT) abdomen was done which revealed a large hypodense inhomogenously enhancing mass (arrow) in the spleen. In addition to the splenic metastasis, metastatic lesions are also seen in the liver with recurrence in the left renal bed [<xref ref-type="fig" rid="F2">Figure 2</xref>].</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Anterior (a) and posterior (b) planar images of 99mTc-methylene diphosphonate (MDP) bone scan. No abnormally increased activity is noted in the bones suggesting no osteoblastic metastasis. A focal area of increased uptake is noted in the left hypochondrium (arrow). The left kidney is not visualized; post nephrectomy status</p></caption><graphic xlink:href="IJNM-29-60-g001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Contrast enhanced computed tomography (CECT) scan; axial (a) sagittal (b) and coronal (c) images reveal a large hypodense inhomogenously enhancing mass (arrow) in the spleen. In addition to the splenic metastasis, metastatic lesions are also seen in the liver with recurrence in the left renal bed (c)</p></caption><graphic xlink:href="IJNM-29-60-g002"/></fig><p>Extraosseous uptake of MDP is not an unusual finding. Published reports have depicted MDP accumulation in liver metastases,[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref>] pericardial metastasis,[<xref rid="ref3" ref-type="bibr">3</xref>] and even metastasis from malignant peripheral nerve sheath tumor.[<xref rid="ref4" ref-type="bibr">4</xref>] In lesions with calcifications seen on morphologic imaging, it is understood that the uptake of MDP is because of its affinity to bind to calcium. But soft tissue uptake in tissues which lack morphologic calcifications have also been documented. A proposed mechanism for MDP accumulation in soft tissue is cellular alterations in calcium metabolism. It is postulated that there is disruption of the cellular membrane through which the bone-seeking radiopharmaceutical gains entry into the cell and is deposited with calcium on the mitochondria or attaches to calcium by displacing other anions.[<xref rid="ref5" ref-type="bibr">5</xref>]</p><p>Metastatic involvement of spleen is uncommon. The incidence of isolated metastasis is less than 1%.[<xref rid="ref6" ref-type="bibr">6</xref>] Metastasis to the spleen from malignant neoplasms is a rare phenomenon and is usually found at autopsy.[<xref rid="ref7" ref-type="bibr">7</xref>] Lung, bones, liver, and brain are the commonest sites of metastatic spread in renal cell cancer.[<xref rid="ref8" ref-type="bibr">8</xref><xref rid="ref9" ref-type="bibr">9</xref>] Splenic metastases are usually asymptomatic. Sometimes the patient may present with abdominal mass or pain, fatigue, and weight loss.[<xref rid="ref10" ref-type="bibr">10</xref>] Many theories have been postulated regarding the rarity of finding metastases to the spleen. It is suggested that it is due to the constant flow of blood through the spleen, the sharp angulation between the splenic and coeliac arteries prevent large tumor cells from passing through it. Also the lack of afferent lymphatic vessels prevents the spread via the lymphogenic route.[<xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref12" ref-type="bibr">12</xref>] Splenic metastases from RCC is quiet rare and only a few cases have been reported. To our knowledge this is the first case being reported, in which MDP has shown accumulation in a rare case of splenic metastasis from RCC.</p></body><back><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romyn</surname><given-names>AM</given-names></name><name><surname>Bushnell</surname><given-names>DL</given-names></name><name><surname>Freeman</surname><given-names>ML</given-names></name><name><surname>Kaplan</surname><given-names>E</given-names></name></person-group><article-title>Visualization of metastatic liver disease on technetium-99m bone scintigraphy</article-title><source>Clin Nucl Med</source><year>1987</year><volume>11</volume><fpage>264</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">3581604</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senda</surname><given-names>M</given-names></name><name><surname>Tamak</surname><given-names>N</given-names></name><name><surname>Torizuka</surname><given-names>K</given-names></name><name><surname>Fujiwara</surname><given-names>Y</given-names></name><name><surname>Kudo</surname><given-names>M</given-names></name><name><surname>Tochio</surname><given-names>H</given-names></name><etal/></person-group><article-title>Accumulation of Tc-99m methylene diphosphonate in calcified metastatic lesions of the liver from colonic carcinoma. Comparison with calcification on X-ray computed tomogram</article-title><source>Clin Nucl Med</source><year>1985</year><volume>10</volume><fpage>9</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">3156710</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawase</surname><given-names>T</given-names></name><name><surname>Fujii</surname><given-names>H</given-names></name><name><surname>Nakahara</surname><given-names>T</given-names></name><name><surname>Shigematsu</surname><given-names>N</given-names></name><name><surname>Kubo</surname><given-names>A</given-names></name><name><surname>Kosuda</surname><given-names>S</given-names></name></person-group><article-title>Intense accumulation of Tc-99m MDP in pericardial metastasis from breast cancer</article-title><source>Clin Nucl Med</source><year>2009</year><volume>34</volume><fpage>173</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">19352284</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Kuang</surname><given-names>A</given-names></name><name><surname>Sheng</surname><given-names>S</given-names></name></person-group><article-title>Tc-99m MDP uptake in retroperitoneal malignant peripheral nerve sheath tumor and its metastases</article-title><source>Clin Nucl Med</source><year>2006</year><volume>31</volume><fpage>44</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">16374127</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasmussen</surname><given-names>H</given-names></name><name><surname>Chance</surname><given-names>B</given-names></name><name><surname>Ogata</surname><given-names>E</given-names></name></person-group><article-title>A mechanism for the reactions of calcium with mitochondria</article-title><source>Proc Natl Acad Sci USA</source><year>1965</year><volume>52</volume><fpage>1069</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">5222550</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunes</surname><given-names>TF</given-names></name><name><surname>Szejnfeld</surname><given-names>D</given-names></name><name><surname>Miiji</surname><given-names>LN</given-names></name><name><surname>Goldman</surname><given-names>SM</given-names></name></person-group><article-title>Isolated metachronous splenic metastasis from renal cell carcinoma after 5 years</article-title><source>BMJ Case Rep 2012</source><year>2012</year></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatsuta</surname><given-names>M</given-names></name><name><surname>Shiozaki</surname><given-names>K</given-names></name><name><surname>Masutani</surname><given-names>S</given-names></name><name><surname>Hashimoto</surname><given-names>K</given-names></name><name><surname>Imamura</surname><given-names>H</given-names></name><name><surname>Ikeda</surname><given-names>M</given-names></name><etal/></person-group><article-title>Splenic and pulmonary metastases from renal cell carcinoma: Report of a case</article-title><source>Surg Today</source><year>2001</year><volume>31</volume><fpage>463</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">11381515</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>AW</given-names></name><name><surname>Chisholm</surname><given-names>GD</given-names></name></person-group><article-title>The natural history of renal carcinoma</article-title><source>Semin Oncol</source><year>1983</year><volume>10</volume><fpage>390</fpage><lpage>400</lpage><pub-id pub-id-type="pmid">6665566</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garza</surname><given-names>CV</given-names></name><name><surname>Perez-Alvarez</surname><given-names>SI</given-names></name><name><surname>Gonzalez-Espinoza</surname><given-names>IR</given-names></name><name><surname>Leon-Rodriguez</surname><given-names>E</given-names></name></person-group><article-title>Unusual metastases in renal cell carcinoma: A single institution experience and review of literature</article-title><source>World J Oncol</source><year>2010</year><volume>1</volume><fpage>149</fpage><lpage>57</lpage></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>KY</given-names></name><name><surname>Tang</surname><given-names>V</given-names></name></person-group><article-title>Metastatic tumors to the spleen: A 25-year clinicopathologic study</article-title><source>Arch Pathol Lab Med</source><year>2000</year><volume>124</volume><fpage>526</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">10747308</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berge</surname><given-names>T</given-names></name></person-group><article-title>Splenic metastases. Frequencies and patterns</article-title><source>Acta Pathol Microbiol Scand</source><year>1974</year><volume>82</volume><fpage>499</fpage><lpage>506</lpage></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comperat</surname><given-names>E</given-names></name><name><surname>Bardier-Dupas</surname><given-names>A</given-names></name><name><surname>Camparo</surname><given-names>P</given-names></name><name><surname>Capron</surname><given-names>F</given-names></name><name><surname>Charlotte</surname><given-names>F</given-names></name></person-group><article-title>Splenic metastases: Clinicopathological presentation, differential diagnosis, and pathogenesis</article-title><source>Arch Pathol Lab Med</source><year>2007</year><volume>131</volume><fpage>965</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17550328</pub-id></element-citation></ref></ref-list></back></article>